Companies /Healthcare

Varex Imaging Corp

NASDAQ: VREX Medical Devices
$18.42
▲ $0.01 (+0.05%) today
Markets closed · 1:01pm ET

24/7 Wall St. View

VREX at a Glance

Valuation
Market cap
$781.8M
P/E ratio
34.7
Profitability
Revenue (TTM)
$865.0M
Profit margin
2.6%
EPS (TTM)
$0.53
Price
52-week range
$9 – $19
Street target
$18.90
Earnings
Next report
Nov 17, 2026
Q3 2026 EPS
$0.31
vs. $0.20 est.
+56.6%

Headquartered in Salt Lake City, UT Fiscal year ends September NASDAQ: VREX vareximaging.com

About Varex Imaging

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components and systems. Its product portfolio includes X-ray tubes, digital flat-panel detectors, image processing software, and connecting devices that serve as critical subsystems within X-ray imaging equipment. The company operates through two segments: Medical, which supplies components to OEM manufacturers of diagnostic imaging, oncology, and dental systems; and Industrial, which provides X-ray imaging components and complete systems for cargo and vehicle inspection, non-destructive testing, and security screening applications. With over 70 years of innovation history, Varex sells to global OEM customers who integrate these components into their own branded systems. The company employs approximately 2,500 people across North America, Europe, and Asia. Varex has announced a pending acquisition by Teledyne Technologies Incorporated. Updated

Revenue by Segment · Q3 2026
  1. Medical64%
  2. Industrial36%

VREX Coverage

Frequently Asked Questions

What does Varex Imaging do?

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components and systems. Its product portfolio includes X-ray tubes, digital flat-panel detectors, image processing software, and connecting devices that serve as critical subsystems within X-ray imaging equipment.

What is the VREX stock price target?

The Wall Street consensus 12-month price target for VREX is $18.90.